Capizzi Rl
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Acute Lymphoblastic Leukemia research 5
-
- Cancer therapeutics and mechanisms 1
- Co-authors
- Frederick Richards (4 shared papers)Cooper Mr (3 shared papers)Muss Hb (1 shared paper)Spurr Cl (2 shared papers)Matthew Poole (1 shared paper)Sartorelli Ac (1 shared paper)Clifton R. White (1 shared paper)White Jc (2 shared papers)
- Journals
- Leukemia (1 paper)Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (14 papers)
- Partner nations
- United States
In The Last Decade
Capizzi Rl
16 papers receiving 398 citations
Peers
Comparison fields: 5 of 67
- Hematology 176
- Genetics 47
- Public Health, Environmental and Occupational Health 128
- Oncology 119
- Radiology, Nuclear Medicine and Imaging 92
Countries citing papers authored by Capizzi Rl
This map shows the geographic impact of Capizzi Rl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Capizzi Rl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Capizzi Rl more than expected).
Fields of papers citing papers by Capizzi Rl
This network shows the impact of papers produced by Capizzi Rl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Capizzi Rl. The network helps show where Capizzi Rl may publish in the future.
Co-authors
The 16 scholars most cited alongside Capizzi Rl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase. | 1984 | 159 |
| 2 | The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine. | 1999 | 124 |
| 3 | Clinical status and optimal use of amifostine. | 1999 | 43 |
| 4 | Combination chemotherapy--theory and practice. | 1977 | 29 |
| 5 | Low dose Ara-C for patients with myelodysplastic syndromes. | 1988 | 17 |
| 6 | Leukapheresis induced changes in cell cycle distribution and nucleoside transporters in patients with untreated acute myeloid leukemia. | 1991 | 12 |
| 7 | S-phase fraction is not correlated with nucleoside transport in acute myeloid leukemia cells. | 1991 | 6 |
| 8 | Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignancies. | 1985 | 6 |
| 9 | Phase II trial of high-dose cytarabine and cisplatin in locoregional previously untreated squamous carcinoma of the head and neck: a Piedmont Oncology Association Study. | 1987 | 6 |
| 10 | The place of pharmacology in cancer medicine. | 1977 | 5 |
| 11 | The pharmacologic basis for the efficacy of high-dose Ara-C and sequential asparaginase in adult acute myelogenous leukemia. | 1988 | 5 |
| 12 | Chemoinfusion of the hepatic artery for metastases to the liver. | 1989 | 3 |
| 13 | Randomized phase II comparison of methotrexate with or without L-asparaginase in non-small cell cancer of the lung. | 1982 | 3 |
| 14 | Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ). | 1983 | 2 |
| 15 | Correlation of the proliferative index of residual leukemia with outcome in patients treated with sequential high dose ara-C and asparaginase. | 1990 | 2 |
| 16 | Cure of hepatic candidiasis in acute leukemia. | 1986 | 1 |
About Capizzi Rl
Capizzi Rl is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 16 papers that have together received 423 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (5 papers), Acute Myeloid Leukemia Research (3 papers), Cancer Treatment and Pharmacology (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Effects of Radiation Exposure (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Cancer therapeutics and mechanisms (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Hematology (176 citations), Genetics (47 citations), Public Health, Environmental and Occupational Health (128 citations), Oncology (119 citations) and Radiology, Nuclear Medicine and Imaging (92 citations). Capizzi Rl has collaborated with scholars based in United States. Frequent co-authors include Frederick Richards, Cooper Mr, Muss Hb, Spurr Cl, Matthew Poole, Sartorelli Ac, Clifton R. White, White Jc, Jesse C. Craig and Smith Lr. Their work appears in journals such as Leukemia, Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.